Aproviso and Vista Clinical Announce Next-Generation Clinical Trial Automation System
Aproviso, Inc., a provider of secure, validated technologies for the life science and health care industries, and Vista Clinical, Inc., the leading innovator of clinical trial automation technology, announced today that they have formed a strategic partnership to deliver next-generation clinical trial automation technologies to the pharmaceutical, biotechnology and medical device industries.
The business arrangement combines validation, hosting, deployment and support services provided by Aproviso with a new, next-generation clinical trial automation platform developed by Vista Clinical. The combination delivers the most powerful technology available under an independent certification (validation) together with a customer-centric focus on deployment and support.
With this alignment, Aproviso and Vista Clinical become the only vendors to offer a clinical trial automation system that can span electronic data capture (EDC), clinical data management (CDM), clinical trial management (CTM), and document management under a secure, fully validated environment that exceeds both 21 CFR 11 and HIPAA regulatory requirements.
“Vista Clinical’s Panorama is the only technology in the space that is capable of fully integrating all aspects of any size of trial,” said Mike Andrus (CEO, Aproviso). “And unlike so many of the competing systems we’ve looked at over the years, it is incredibly powerful and yet very intuitive to setup, administer, use, and support. Rawld Gill (CEO, Vista Clinical) invented EDC more than 20 years ago, and we are excited to be part of the advanced paradigm that Vista Clinical is introducing to the industry.”
“Aproviso brings extensive, best-in-class computer systems validation experience to the table. They have a sterling track record, including work with top-five pharmaceutical companies. This level of service and credibility allows customers to employ our new technologies with confidence,” said Rawld Gill. “Everybody knows the current ‘market leading’ solutions are just not working. Some customers are concerned about risks consequent to employing a new technology. Aproviso’s validation, hosting, and support services eliminate these risks.”
Aproviso and Vista Clinical will be showcasing this technology at booth #2108 at BIO 2005, June 19-22 at the Pennsylvania convention center in Philadelphia, PA.
About Vista Clinical
Established in 2000, Vista Clinical delivers next-generation clinical trial automation technology that decreases trial track time, simplifies trial work processes, improves trial quality, and decreases trial cost. Panorama Clinical, the company’s flagship product, is able to subsume one, some or all of electronic data capture, clinical data management, clinical trial management, and document management. Unlike competing systems that integrate independent systems, the functionality is provided by a single, powerful, enterprise-class system that can integrate with legacy systems as required. No competing technology offers these capabilities. www.vistaclinical.com
About Aproviso
Aproviso is a technology management company that provides IT solutions to companies worldwide, with a vertical emphasis in the life science and healthcare industry. Aproviso specializes in regulatory compliance (21 CFR Part 11, HIPAA), information security, and clinical trial management. Aproviso’s validation experience in business applications is focused primarily to data management and document retention as it relates to electronic records and signatures. Aproviso’s specialized staff has extensive backgrounds in IT, with hands-on experience in the assessment, development, implementation, validation, verification and remediation of computer systems. www.aproviso.com
